Production of siRNA-Loaded Lipid Nanoparticles using a Microfluidic Device

Overview

This article presents a protocol for the production of siRNA-loaded lipid nanoparticles (LNPs) using a microfluidic device called iLiNP. The method allows for precise control over LNP size, which is crucial for effective drug delivery systems.

Key Study Components

Area of Science

• Drug delivery systems
• Lipid nanoparticles
• Microfluidics

Background

• Lipid nanoparticle size influences biodistribution and therapeutic efficacy.
• Control of LNP size is essential for optimizing RNA delivery.
• The iLiNP device enables size control from 20 to 100 nanometers.
• Electrostatic interactions facilitate siRNA encapsulation in LNPs.

Purpose of Study

• To develop a reliable method for producing siRNA-loaded LNPs.
• To evaluate the impact of LNP size on gene silencing efficiency.
• To optimize flow conditions for desired LNP characteristics.

Methods Used

• Preparation of lipid and aqueous solutions for LNP production.
• Use of the iLiNP device for mixing and LNP formation.
• Dialysis of LNP suspensions to remove excess materials.
• Dynamic light scattering to measure LNP size and distribution.

Main Results

• The iLiNP device produced siRNA-loaded LNPs with a size of 90 nanometers and 95% encapsulation efficiency.
• Small LNPs were formed under high total flow rate conditions.
• siRNA-loaded LNPs demonstrated cytotoxicity and effective gene silencing.
• Optimized flow conditions were critical for achieving desired LNP sizes.

Conclusions

• The microfluidic method using the iLiNP device simplifies LNP production.
• This approach is expected to standardize LNP production in research.
• Further studies can explore the application of this method in various RNA delivery systems.

Frequently Asked Questions